Sub Topics: Neurons and glial cells ,Neurotransmitters and receptors ,Neural plasticity...
In a cutting-edge neurosurgical facility, a neurosurgeon, Dr. Laura Bennett, is approached by a 35-year-old, healthy individual, John, a high-performing executive who works long hours in a high-stakes business environment. John expresses interest in undergoing Deep Brain Stimulation (DBS), a procedure originally developed for Parkinson’s disease and major depressive disorder, to enhance his cognitive abilities—specifically improving his focus, memory, and overall cognitive performance. He believes that DBS could provide him with a competitive edge in his professional career and help him manage the increasing demands of his job.
Dr. Bennett is a highly skilled neurosurgeon, known for her expertise in neurostimulation techniques. While DBS has been shown to have profound effects on patients with neurological disorders, the procedure has never been performed on a healthy individual for purely enhancement purposes. As such, she is unsure how to approach John’s request.
This case raises multiple ethical concerns:
Medical Necessity vs. Enhancement
Informed Consent
Safety and Long-Term Risks
Equity and Access
Slippery Slope: Societal Implications
Beneficence vs. Enhancement: Dr. Bennett must carefully evaluate whether performing DBS for enhancement serves the overall well-being of the patient or society. While cognitive enhancement could provide benefits for John’s career, it might not be justifiable in the absence of a medical need. The procedure carries risks that could result in unintended negative outcomes, which might outweigh the potential benefits. Medical enhancement may be perceived as a “luxury” for the privileged few, rather than a necessary intervention for improving quality of life.
Informed Consent: Dr. Bennett must provide John with a clear explanation of the potential risks, including the unknown long-term consequences. A thorough discussion should take place about the ethical concerns surrounding performance enhancement, allowing John to make an informed decision about whether to proceed with DBS. Additionally, there should be an emphasis on making sure John’s decision is free of coercion, meaning he should feel no undue pressure from societal or professional expectations.
Non-Maleficence and Safety: Given that the effects of DBS on healthy individuals are largely unknown, Dr. Bennett has a responsibility to ensure that John is fully aware of the risks. Even if the procedure offers cognitive benefits, any potential harm must be carefully weighed. If John is not experiencing a medical condition, the ethical question arises: Is it justifiable to expose him to the inherent risks of a procedure that may not be fully proven in a healthy brain?
Equity and Justice: The decision to allow DBS for enhancement in healthy individuals might lead to increased inequality in society. If such procedures become mainstream, only wealthy individuals may have access to them, potentially creating a two-tiered society where cognitive abilities and productivity are optimized only for the privileged. Dr. Bennett must consider these broader societal implications before performing any enhancements.
Slippery Slope and Societal Implications: If the line between treatment and enhancement becomes blurred, it may lead to an increasing demand for non-therapeutic medical interventions to improve human traits. Neurosurgeons may be faced with growing ethical pressure to perform enhancements that are not medically necessary, leading to potential societal and cultural shifts that could redefine what is considered “normal.”